Separation of retinoid-induced epidermal and dermal thickening from skin irritation
- 141 Downloads
The ability of the synthetic retinoid MDI-301, in which the carboxylic acid of 9-cis-retinoic acid (9-cis-RA) is replaced with an ester linkage, to induce epidermal and dermal thickening and skin irritation (erythema and flaking) in hairless (rhino) mice following its topical application was investigated in comparison with that of 14-all-trans-retinoic acid (14-all-trans-RA) and 9-cis-RA. MDI-301 induced epidermal proliferation leading to a thickened epidermis. Treated animals also demonstrated a prominent band of organized connective tissue immediately below the epidermis. In its ability to induce epidermal thickening, MDI-301 was quantitatively similar to 14-all-trans-RA and 9-cis-RA. However, unlike 14-all-trans-RA and 9-cis-RA, which produced skin irritation associated with a perivascular influx of mononuclear leukocytes into the dermis, there was no evidence of irritation with MDI-301 and little leukocyte infiltration. Intraperitoneal injection of either 14-all-trans-RA or MDI-301 also resulted in epidermal and dermal thickening. Irritation of skin was not observed in these animals but splenomegaly was prominent in animals treated with either agent.
KeywordsRetinoids Epidermal hyperplasia Dermal thickening Irritation
This study was supported in part by grants AR 49621 and DK 59169 from the USPHS. The authors would like to thank Molecular Design International, Inc. (MDI) of Memphis, TN, for supplying MDI-301.
- Duell EA, Astrom A, Griffiths EC, Chambon P, Voorhees JJ (1992) Human skin levels of retinoic acid and cytochrome P-450-derived 4-hydroxyretinoic acid after topical application or retinoic acid in vivo as compared to concentrations required to stimulate retinoic acid-mediated transcription in vitro. J Clin Invest 90:1269–1274PubMedGoogle Scholar
- Durand A, Bun H, Marchetti MN (1996) Preliminary development of a bioanalytical method for measuring MDI-301 and potential metabolites and its application to rat plasma samples (Technical Report). Molecular Design International, Memphis, TNGoogle Scholar
- Kang S, Duell EA, Fisher GJ, Datta SC, Wang Z-Q, Reddy AP, Tavakkol A, Yi Y, Griffiths CEM, Elder JT, Voorhees JJ (1995) Application of retinol to human skin in vivo induces epidermal hyperplasia and cellular retinoid binding proteins characteristic of retinoic acid but without measurable retinoic acid levels or irritation. J Invest Dermatol 105:549–556PubMedGoogle Scholar
- Luger TA, Schwartz T (1990) Evidence for an epidermal cytokine network. J Invest Dermatol 935:100s–104sGoogle Scholar
- Purcell WP (1998) US Patent 5,837,728, November 17Google Scholar
- Varani J, Nickoloff BJ, Dixit VM, Mitra RS, Voorhees JJ (1989) All-trans retinoic acid stimulates growth of adult human keratinocytes cultured in growth factor-deficient medium, inhibits the production of thrombospondin and fibronectin and reduces adhesion. J Invest Dermatol 93:449–454PubMedGoogle Scholar
- Varani J, Warner RL, Mehrnaz G-K, Phan SH, Kang S, Chung JH, Wang ZQ, Datta SC, Fisher GJ, Voorhees JJ (2000) Vitamin A antagonizes decreased cell growth and elevated collagen-degrading matrix metalloproteinases and stimulates collagen accumulation in naturally aged human skin. J Invest Dermatol 114:480–486CrossRefPubMedGoogle Scholar
- Varani J, Zeigler M, Dame MK, Kang S, Fisher GJ, Voorhees JJ (2001) Heparin-binding epidermal growth factor-like growth factor activation of keratinocyte ErbB receptors mediates epidermal hyperplasia, a prominent side-effect of retinoid therapy. J Invest Dermatol 117:1335–1341CrossRefPubMedGoogle Scholar
- Wood LC, Elias PM, Calhoun C, Tsai JC, Grunfeld C, Feingold KR (1996) Barrier disruption stimulates interleukin-1α expression and release from a pre-formed pool in murine epidermis. J Invest Dermatol 106:397–403Google Scholar